London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

UK stocks today (6 Nov 2025): FTSE 100 edges lower before BoE decision; Sainsbury lifts profit guidance, ITV warns on Q4 ads, AstraZeneca beats

LONDON — Thursday, 6 November 2025

At a glance

  • FTSE 100 trades slightly lower as investors await the Bank of England’s rate call; sterling holds near multi‑month lows. [1]
  • Construction PMI slumps to 44.1 in October, the sharpest contraction in over five years, underscoring a soft UK backdrop. [2]
  • Earnings & updates:
    • J Sainsbury raises FY retail underlying operating profit guidance to “more than £1bn” and confirms an 11p special dividend. [3]
    • ITV flags ~9% YoY decline in Q4 total ad revenue and unveils £35m temporary savings. [4]
    • AstraZeneca beats Q3 revenue and core EPS but keeps full‑year guidance unchanged. [5]
    • Smith & Nephew shares drop ~9% on softer US knee‑implant sales. [6]
    • Diageo posts flat organic net sales in fiscal Q1 (volume +2.9%) and trims full‑year sales outlook. [7]
    • Hikma reaffirms 2025 guidance but lowers medium‑term growth targets. [8]
    • LSEG announces a private‑markets data partnership with Nasdaq. [9]

Market snapshot: waiting on Threadneedle Street

UK equities were fractionally lower by late morning, with traders staying cautious ahead of the Bank of England’s midday decision and press conference. The FTSE 100 drifted as much as about 0.3%, while sterling hovered near recent lows against major peers amid growth concerns and budget uncertainty later this month. [10]

Fresh data reinforced the slowdown narrative: the S&P Global/CIPS Construction PMI fell to 44.1 in October (from 46.2), marking the fastest drop in activity since May 2020 and the longest downturn since the financial crisis. Civil engineering led the decline, with housing also weak. [11]

One pocket of strength: UK bank shares modestly outperformed after reports the sector may avoid a punitive tax raid in the upcoming Budget, lifting the FTSE 350 Banks index. [12]


Big movers & newsmakers

Sainsbury: guidance upgrade, special payout

J Sainsbury (SBRY) said first‑half trading was ahead of expectations and raised its full‑year retail underlying operating profit target to “more than £1bn.” It also confirmed an 11p special dividend on 19 December and outlined additional buyback plans linked to its bank disposals. The retailer cited grocery volume growth, improving value perception and cost savings. [13]

ITV: strong Studios & digital, but Q4 ad headwinds

ITV (ITV) reported +2% group revenue YTD to £2.80bn, driven by +11% Studios and +15% digital ad growth. However, management warned Q4 total advertising revenue is expected to be down ~9% YoY, citing broad caution ahead of the late‑November Budget. ITV will make £35m temporary savings (including £20m by moving content into 2026) to offset the revenue hit. [14]

AstraZeneca: beats, but no guidance raise

AstraZeneca (AZN) delivered a Q3 beat on revenue and core EPS thanks to oncology and cardiovascular drugs, but left its full‑year outlook unchanged, which some investors had hoped would be lifted. The company highlighted pipeline progress and reiterated long‑term ambitions. [15]

Smith & Nephew: revenue miss bites

Smith & Nephew (SN.) shares fell around 9% after Q3 revenue (~$1.50bn) missed estimates, with US knee‑implant sales singled out as a weak spot. The company kept its annual revenue and margin guidance unchanged, but the US orthopaedics softness dominated sentiment. [16]

Diageo: flat volumes up, price/mix down; outlook nudged

Diageo (DGE) posted flat organic net sales in fiscal Q1 (volume +2.9%) as growth in Europe, LAC and Africa was offset by Chinese white spirits weakness and a softer US spirits market. Diageo now expects FY26 organic net sales to be flat to slightly down, but still targets ~$3bn free cash flow this year as its “Accelerate” cost‑saving programme progresses. [17]

Hikma: 2025 intact, medium‑term trimmed

Hikma (HIK) reaffirmed 2025 guidance (group revenue growth 4–6%; core operating profit $730–$750m), but revised lower its 2024–2027 CAGR and Injectables margin expectations as its Bedford US facility timeline pushes out toward late 2027. [18]

LSEG x Nasdaq: private‑markets data tie‑up

London Stock Exchange Group (LSEG) unveiled a strategic partnership with Nasdaq to distribute private‑markets datasets (including eVestment content) via LSEG Workspace and datafeeds—an extension of LSEG’s recent push into private‑company infrastructure. [19]


Why it matters

  • The BoE decision arrives into a weak domestic backdrop (construction slump, cautious consumers and advertisers), alongside a soft currency—all levers that can magnify policy impact on bank, housebuilder and domestically focused mid‑cap shares. [20]
  • Corporate updates show a bifurcated market: staples/retailers are leaning on cash returns and execution (Sainsbury), media is feeling the cyclical ad slowdown (ITV), while healthcare names are moving on pipeline and mix (AstraZeneca; Smith & Nephew). [21]
  • Banks’ relative outperformance today underlines how fiscal signals can swing sector leadership in the run‑up to November’s Budget. [22]

What to watch next (today)

  • Bank of England policy decision & vote split — market reaction in gilts, sterling, banks, and UK domestic cyclicals. [23]
  • Company calls and press briefings from today’s reporters (notably AstraZeneca, ITV, Diageo, Hikma) for colour on 2026 planning, cost actions, and demand signals. [24]

Sources & further reading

  • Market & macro: UK stocks and FX pre‑BoE; UK banks rally; UK Construction PMI. [25]
  • Company updates: Sainsbury H1 results; ITV Q3 trading update; AstraZeneca Q3; Smith & Nephew Q3 price reaction; Diageo F26 Q1; Hikma trading update; LSEG–Nasdaq partnership. [26]

This report is for information only and does not constitute investment advice. Market levels and share prices referenced above reflect conditions reported during the UK morning session on 6 November 2025.

Bloomberg Business News Live

References

1. www.reuters.com, 2. www.reuters.com, 3. corporate.sainsburys.co.uk, 4. www.itvplc.com, 5. www.reuters.com, 6. www.reuters.com, 7. www.diageo.com, 8. www.hikma.com, 9. www.tradingview.com, 10. www.reuters.com, 11. www.reuters.com, 12. www.reuters.com, 13. corporate.sainsburys.co.uk, 14. www.itvplc.com, 15. www.reuters.com, 16. www.reuters.com, 17. www.diageo.com, 18. www.hikma.com, 19. www.tradingview.com, 20. www.reuters.com, 21. corporate.sainsburys.co.uk, 22. www.reuters.com, 23. www.reuters.com, 24. www.reuters.com, 25. www.reuters.com, 26. corporate.sainsburys.co.uk

Stock Market Today

  • October layoff spike: Challenger data shows worst month in over 20 years for U.S. layoffs
    November 6, 2025, 10:59 AM EST. Last month marked the worst October for layoff announcements in more than two decades, with 153,074 cuts and 1.099 million through the first 10 months of the year, per Challenger, Gray & Christmas. The report shows technology firms leading private-sector layoffs as companies trim payrolls to conserve cash amid AI adoption, slower consumer spending, and rising costs. The data imply a tightening labor market and a slower pace of hiring, with year-to-date cuts at their highest since 2020. Notable announcements from Amazon, Target, and UPS underscore broad industry pressure. With government data limited by a shutdown, the October jobs picture remains unsettled even as ADP shows modest private-sector gains.
  • Stocks set for tiny gains ahead of the open on mixed earnings
    November 6, 2025, 10:54 AM EST. U.S. stock futures point to tiny gains ahead of the opening bell as investors digest mixed corporate earnings. Traders weigh stronger results from some companies against softer reports and scrutinize outlooks, margins, and guidance. A cautious tone persists as markets await a light but potentially volatile session, with attention on how earnings shape expectations for the broader market and the upcoming data.
  • NYSE Pre-Market Update: Evommune & Aeromexico IPOs Begin Trading; Altice Rename to Optimum, Ticker OPTU
    November 6, 2025, 10:53 AM EST. Today's NYSE pre-market update shows stocks little changed after a rebound led by AI names. Oracle rose nearly 1% on the session. The spotlight: Evommune debuts on the NYSE after pricing at $16 a share, raising $150 million to advance treatments for chronic inflammatory diseases like eczema and hives. Grupo Aeromexico also priced its IPO at $19, raising about $223 million as it rounds into service for global connections from Mexico. Altice USA will rename to Optimum Communications and trade under the ticker OPTU starting November 19. Opening Bell featured Evommune's IPO celebration; Closing Bell highlighted Arrow Electronics' 90th anniversary. Ashley Mastronardi handled the pre-market update.
  • Nio Stock Price Prediction 2025-2030: Tailwinds, Headwinds, and Long-Term Outlook
    November 6, 2025, 10:50 AM EST. NIO stock has faced tariff-driven volatility, hitting a multiyear low around $3.02, but rebounded and is up 67.2% year-to-date after a week of gains driven by record deliveries and higher revenue forecasts. A Singapore sovereign wealth fund lawsuit remains a headwind. Shares are 83.2% above six months ago, slightly ahead of the S&P 500; about half of 27 analysts rate it a buy, with a mean target of $6.91 and a high target of $9.02. Tailwinds include 600-mile range high-performance models and battery-swap technology, plus growing international presence. While the stock has been a two-story tale since its 2018 NYSE debut, the long-term outlook remains bullish, with 24/7 Wall St. projecting meaningful gains by 2030.
  • Under Armour Q3 Revenue Beats Estimates, But Margins and EBITDA Miss Highlight Tough Turnaround
    November 6, 2025, 10:47 AM EST. Under Armour (NYSE: UAA) posted Q3 CY2025 revenue of $1.33 billion, topping Street estimates of $1.31 billion but YoY sales fell 4.7%. Adjusted EPS of $0.04 beat consensus by $0.02, yet Adjusted EBITDA came in at $31.81 million vs $67.04 million expected, a sizable miss. The company guided full-year EPS at $0.04 midpoint, well below analysts' view. Operating margin compressed to 1.3% from 12.4% a year ago. Free Cash Flow was -$90.32 million (vs -$367.2 million a year earlier). Constant-currency revenue declined about 6% in the quarter, with modest signs of brand momentum in North America per CEO Kevin Plank. Analysts see revenue flat next year, implying a cautious near-term outlook for top-line growth.
Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025
Previous Story

ASX Today: S&P/ASX 200 edges up 0.3% to 8,828 as gold miners shine; James Hardie halted, NAB slips — 6 Nov 2025

Wall Street Braces for Shutdown: Stocks Rally as Fed Cuts Loom – Tech & Defense in Focus
Next Story

Hong Kong stocks today (Nov 6, 2025): Hang Seng jumps 2.1% as chips & commodities surge; Pony.ai and WeRide sink on Hong Kong debut

Go toTop